World Library  
Flag as Inappropriate
Email this Article

Difemetorex

Article Id: WHEBN0026674462
Reproduction Date:

Title: Difemetorex  
Author: World Heritage Encyclopedia
Language: English
Subject: Aminorex, A-77636, Levopropylhexedrine, 6-Br-APB, Fenbutrazate
Collection: Alcohols, Anorectics, Norepinephrine-Dopamine Reuptake Inhibitors, Piperidines, Stimulants
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Difemetorex

Difemetorex
Systematic (IUPAC) name
2-[2-(diphenylmethyl)piperidin-1-yl]ethanol
Clinical data
Legal status
  • Withdrawn
Routes Oral
Identifiers
CAS number
ATC code None
PubChem
ChemSpider
UNII  YesY
ChEMBL
Chemical data
Formula C20H25NO 
Mol. mass 295.42 g/mol

Difemetorex (INN; sold as Cleofil), also known as diphemethoxidine, is a stimulant drug of the piperidine class which was used as an appetite suppressant, but produced intolerable side effects such as insomnia which limited its clinical use.[1][2][3][4][5] It was introduced in France by Ciba-Geigy in 1966 but is now no longer marketed.[6]

See also

References

  1. ^ Isbell H, Chrusciel TS. Dependence Liability of Non-Narcotic Drugs. Bulletin of the World Health Organisation 1970; 43: Supplement.
  2. ^ Stepanek, J; Zolliker, VR (1971). "Circulatory effects of the anorectic Diphemethoxidine compared with the effects of Amphetamine and Aminorex". Archives internationales de pharmacodynamie et de therapie 191 (2): 376–99.  
  3. ^ Stepanek, J (1972). "Alteration of the acid-base equilibrium by the anorectic diphemethoxidine in comparison with the effect of amphetamine and aminorex". Archives internationales de pharmacodynamie et de therapie 199 (1): 122–38.  
  4. ^ Hall, Judith A.; Morton, Ian (1999). Concise dictionary of pharmacological agents: properties and synonyms. Kluwer Academic.  
  5. ^ "The use of common stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances" (PDF). Retrieved 2010-03-23. 
  6. ^ Brudon, Pascale (1983). Médicaments pour tous en l'an 2000?: les multinationales pharmaceutiques suisses face au tiers monde : l'exemple du Mexique. France: Editions d'En bas. p. 207.  
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 



Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.